GlassScriptPhysician profile
Kim David Flora
NPI 1033117106
$477.59
in general payments reported to CMS, 2019-2025
10 companies · $15.40 in 2025
The $15.40 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $17.01 · 2021: $47.03 · 2022: $122 · 2024: $151 · 2025: $15.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $119 · Food and Beverage: $47.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $119.00 |
| Food and Beverage | $47.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $125.00 | 2019 | |
| Djo, LLC | $119.00 | 2024 | Dr Comfort |
| Orthofix Medical, INC. | $106.31 | 2022 | |
| Lilly USA, LLC | $27.87 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.75 | 2021 | |
| Smith+Nephew, INC. | $17.01 | 2020 | |
| Medtronic, INC. | $16.66 | 2024 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $15.40 | 2025 | Varivax, M-M-R II, Gardasil 9 |
| Alfasigma USA, INC. | $15.36 | 2021 | |
| Amgen INC. | $15.23 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Flora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.